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ABSTRACT
Background: Antepartum, intrapartum, and postpartum preventive measures with 
antiretroviral drugs, appropriate delivery methods, and discouraging breastfeeding 
significantly decrease the risk of mother-to-child transmission of human immunodeficiency 
virus (HIV) infection. Herein, we investigated the pregnancy outcomes in HIV-infected 
Korean women.
Methods: We retrospectively reviewed medical records of childbearing-age HIV-infected 
women between January 2005 and June 2017 at four tertiary care hospitals in Korea.
Results: Among a total of 95 HIV infected women of child-bearing age with 587.61 years of 
follow-up duration, 15 HIV-infected women experienced 21 pregnancies and delivered 16 
infants. The pregnancy rate was 3.57 per 100 patient-years. Among the 21 pregnancies, five 
ended with an induced abortion, and 16 with childbirth including two preterm deliveries at 
24 and 35 weeks of gestation, respectively. The two preterm infants had low birth weight and 
one of them died 10 days after delivery due to respiratory failure. Among the 14 full-term 
infants, one infant was small for gestational age. There were no HIV-infected infants.
Conclusion: The pregnancy rate of HIV-infected women in Korea is lower than that of the 
general population. Although several adverse pregnancy outcomes were observed, mother-
to-child transmission of HIV infection was successfully prevented with effective preventive 
measures.
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INTRODUCTION
Human immunodeficiency virus (HIV) can be transmitted from mother to child. But, with 
effective preventive measures including universal prenatal HIV counseling and testing, 
preconception care, antiretroviral prophylaxis, scheduled cesarean section delivery, and 
avoidance of breastfeeding, the perinatal transmission rate has decreased to < 2% among HIV-
exposed infants in developed countries.1-3 Even though preventive measures could significantly 
lower the transmission rate, HIV-infected women, particularly those with advanced disease, 
may have adverse pregnancy outcomes such as preterm birth, low birth weight, and neonatal 
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death.4-6 Although there have been single-center studies about the prevention of mother-to-child 
HIV transmission and few mother-to-child transmission cases have been reported by Korea 
Centers for Disease Control and Prevention (KCDC), a multicenter-based study on pregnancy 
rate and adverse pregnancy outcomes of HIV-infected women has not been performed, yet.7-9 
This study investigated the pregnancy rates and outcomes in HIV-infected Korean women.
METHODS
Study sites and data collection
We retrospectively reviewed medical records of childbearing-aged (18–50 years) HIV-infected 
women between January 2005 and June 2017 at four tertiary care hospitals: they were located 
at Seoul (with 2,400 beds), Suwon (with 1,000 beds), Incheon (with 900 beds) and Wonju 
(with 850 beds).
HIV-infected mother
Data were collected on maternal status including age, CD4+ cell counts, HIV viral loads, and 
antiretroviral treatment regimens at the time of the 3rd trimester of pregnancy; preventive 
measures including antepartum antiretroviral treatment, zidovudine intravenous injection 
during delivery, cesarean section delivery, avoidance of breastfeeding, and administration of 
zidovudine syrup to the newborn; and birth outcomes. The number of weeks of pregnancy was 
determined by examinations at the Department of Obstetrics and Gynecology of each hospital. 
The follow-up duration was calculated from the first date of visit to the last date of visit.
HIV-exposed infant
HIV viral load and HIV antigen/antibody for delivered children were tested within 48 hours, at 
one–two months, at three–six months, and at 18 months after birth. Quantitative polymerase 
chain reaction (PCR) assay was performed for measurement of HIV viral load.
Definition
A birth earlier than 37 weeks was considered preterm, and birth weight lower than 2,500 g 
was considered low birth weight. Babies with a body weight below the 10th percentile for 
their age and sex were considered small for gestational age.10 Neonatal death was defined as 
death within 28 days of life. If HIV viral loads were negative three consecutive times within 
six months and HIV antigen/antibody test was also negative at 18 months, the newborn was 
considered HIV-negative.
Ethics statement
This study was approved by the Institutional Review Board of Severance Hospital (4-2017-
0556) which waived informed consent because of its retrospective design.
RESULTS
There were a total of 95 childbearing-aged HIV-infected women and the total follow-up 
duration was 587.61 years. The pregnancy rate was 3.57 per 100 patient-years.
Among the 15 HIV-infected women, 21 pregnancies were recorded. Five pregnancies from 
four HIV-infected women were terminated with induced abortions. Fourteen HIV-infected 
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women gave birth to a total of 16 children: two HIV-infected women gave birth twice during 
the study period. Two out of 16 children were born earlier than 37 weeks.
Table 1 shows maternal status and pregnancy outcomes among 21 pregnancies. The mean 
age of the mothers was 28. 9 ± 3.4 (range, 25–39) years. As for marital status at the time of 
pregnancy, 17 (81.0%) were married, three (14.3%) were never married, and one (4.8%) was 
divorced. The partner's HIV status was positive in five (23.8%), negative in 12 (57.1%), and 
unknown in four (19.0%) pregnancies.
The median CD4+ T cell counts of HIV-infected women who delivered children were 507 
± 58 (110–804) cells/μL in their 3rd trimester (Table 2). The antepartum viral loads in 3rd 
trimester were suppressed (< 50 copies/mL) in 12 (75%) deliveries, two of the mothers who 
were unsuppressed (50–1,000 copies/mL) received antiretroviral therapy (ART) before 
conception and the other two mothers (10,000–100,000 copies/mL) received ART from 3rd 
trimester. Antepartum ART was given to all of 16 pregnancies and half of them was started 
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Table 1. Maternal status and pregnancy outcomes among 21 pregnancies
Characteristics Values
Age, yr 28.9 ± 3.4 (25–39)
Marital status, No. (%)
Married 17 (81.0)
Never married 3 (14.3)
Separated 1 (4.8)
Pregnancy outcome, No. (%)
Live birth 16 (76.2)
Stillbirth 0 (0)
Spontaneous abortion 0 (0)
Induced abortiona 5 (23.8)
Data are presented as mean ± standard deviation (range).
aOne ectopic pregnancy was included.
Table 2. Maternal status and preventive measures among 16 pregnancies with live birth
Characteristics Values
Age, yr 29.5 ± 0.9 (25–39)
CD4+ T cell counts in 3rd trimester, cells/µL 507 ± 58 (110–804)
HIV viral loads in 3rd trimester, copies/mL, No. (%)
< 50 12 (75)
50–1,000 2 (12.5)
10,000–100,000 2 (12.5)
100,000–1,000,000 0 (0)
Dates starting antiretroviral treatment, No. (%)
Before conception 8 (50)
1st trimester 2 (12.5)
2nd trimester 3 (18.8)
3rd trimester 3 (18.8)
Antepartum antiretroviral treatment, No. (%)
PI-based regimen 12 (75)
NNRTI-based regimen 1 (6.3)
INSTI-based regimen 1 (6.3)
Zidovudine monotherapy 1 (6.3)
Others 1 (6.3)
Intravenous zidovudine injection during delivery, No. (%) 16 (100)
Cesarean section delivery, No. (%) 15 (93.8)
Zidovudine syrup for infants, No. (%) 16 (100)
Data are presented as mean ± standard deviation (range).
PI = protease inhibitor, NNRTI = non-nucleoside reverse transcriptase inhibitor, INSTI = integrase strand transfer 
inhibitor.
before conception. As for antepartum ART regimens, 12 (75%) received protease inhibitor 
(PI) based ART. One zidovudine monotherapy was given in 2005. Intravenous zidovudine 
was administered to all mothers during delivery. Fifteen (95%) infants were delivered by 
cesarean sections. Zidovudine syrup was administered for six weeks and breastfeeding was 
discouraged for all the infants. We followed-up 13 babies with HIV RNA PCR and antigen/
antibody test until 18 months and no infant was confirmed as positive for HIV infection.
Among the 16 live births, there were three infants with adverse outcomes (Table 3). The 
three infants came from different mothers. One preterm infant was delivered by unplanned 
cesarean section due to vaginal bleeding at 24 weeks of gestation, with a birth weight of 870 g. 
His mother did not have any comorbidities except HIV infection with suppressed viral loads 
and CD4+ T cell counts of 770 cells/μL. The baby died 10 days after delivery due to respiratory 
distress. Another preterm infant was also delivered by cesarean section due to vaginal bleeding 
at 35 weeks of gestation. Her birth weight was 2,280 g and her mother also did not have any 
comorbidities except HIV infection with suppressed viral loads. Thus, these two preterm 
infants had low birth weights. Another infant with small for gestational age and was delivered 
by scheduled cesarean section at 38 weeks of gestation. Her birth weight was 2,620 g. Her 
mother also had no comorbidities other than HIV infection with suppressed viral loads.
DISCUSSION
HIV-infected women tend to avoid pregnancy through contraception and abstinence 
because of anticipated adverse outcomes such as preterm birth, low birth weight, small for 
gestational age, stillbirth, neonatal death, and mother-to-child transmission.7,11,12 However, 
the pregnancy rate has increased, which may be attributed to the widespread application of 
highly active antiretroviral therapy (HAART), which has resulted in a decrease in mother-to-
child transmission.1,13,14 In our study population, the pregnancy rate of HIV-infected women 
of childbearing age was 3.57 per 100 patient-years, which was lower than the rates reported by 
other countries (7.4 in the United States and 7.8 in sub-Saharan Africa).11,14 The birth rate of 
child-bearing aged women (20–49 years) in the Korean general population is generally higher 
than HIV-infected women: 3.71 per 100 woman-years in 2005 and 4.03 per 100 woman-years 
in 2015, respectively.15 The pregnancy rate of the general population would be higher than 
the birth rate. We could not evaluate the effect of scaling up of HAART because the pregnancy 
rate of HIV-infected women in Korea was not previously reported. There were 16 live births 
and five induced abortions among 21 pregnancies. One induced abortion was therapeutic 
termination due to ectopic pregnancy. The induced abortion of HIV-infected women is 
known to be more prevalent than non-infected women,16 and our study showed a high rate 
(23.8%) of induced abortion among HIV-infected pregnant women in Korea. Exceeding 
concerns of mother-to-child transmission could give rise to the low rate of pregnancy and 
high rate of induced abortion.
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Table 3. Adverse outcomes among 16 pregnancies with live birth
Adverse birth outcomes, No. of pregnancies (%) Values
Preterm deliverya 2 (12.5)
Low birth weighta 2 (12.5)
Small for gestational age 1 (6.3)
Neonatal deatha 1 (6.3)
Mother-to-child transmission of HIV infection 0 (0)
aOne infant was included in each variable.
To prevent mother-to-child transmission, antepartum, intrapartum, and postpartum 
preventive measures are recommended. All pregnant women are to receive HIV screening 
tests, ART, avoid breastfeeding, and health care providers must try to minimize exposure of 
the fetus to mother's blood and body fluids.1,2 According to our result, all mentioned 
preventive measures seem to be provided properly. All mothers received antepartum ART, 
zidovudine intravenous infusion during delivery. Furthermore, all infants received 
zidovudine therapy after delivery. As a result, mother-to-child transmission was not 
observed in this study. Two mothers with HIV RNA > 10,000 copies/mL at the 3rd trimester 
underwent scheduled cesarean section and their children were not infected with HIV. 
According to a KCDC report, there were 560 HIV-infected women in childbearing age and 
four mother-to-child HIV transmission cases occurred between 2005 and 2015.9 
Considering the KCDC report and pregnancy rate among HIV-infected women from our 
study (3.57 per 100 patient-years), the presumptive rate of mother-to-children transmission 
is estimated to be 1.82% (
4560 ×  11 ×  0.0357 × 100 ), and it is considered to be eliminated by World 
Health Organization (WHO) criteria.17
A total of three (18.8%) HIV-exposed infants showed adverse outcomes: two (12.5%) preterm 
births, two (12.5%) low birth weight, one (6.3%) small for gestational age, and one (6.3%) 
neonatal death. According to a Korean study, the rate of preterm birth and low birth weight 
were 5.9% and 5.0%, respectively, in 2010.18 Although the rate of adverse birth outcomes was 
higher than that of the general population, the rates were similar to the incidence in other 
countries of HIV-infected women, with a preterm birth rate of 13.0% in the United Kingdom 
and a 23.7% preterm birth rate, an 18.4% small for gestational age rate and a 2.3% neonatal 
mortality rate in Botswana.4,12,19,20 A meta-analysis reported increased risk for preterm birth, 
low birth weight, small for gestational age, and stillbirth in women who have not received 
ART compared those who received ART.12 Although all mothers of our study received ART, 
50% of mothers started ART after conception, and 25% of mothers had unsuppressed viral 
loads in 3rd trimester. Fortunately, there was no adverse outcome in infants from mothers 
with unsuppressed viral loads in 3rd trimester in the present study. In fact, high viral load 
is a known risk factor for preterm birth and low birth weight.5 Therefore, more efforts are 
necessary to screen and treat HIV infection for pregnant women in order to prevent adverse 
birth outcomes. Several studies reported that HAART or a PI-based regimen is associated 
with preterm birth, and it was also reported that administration of a PI-based regimen in 
the first trimester increases the risk of preterm birth.6,20,21 Nine pregnant women who were 
treated with a PI-based regimen before pregnancy or during the first trimester were included 
in this study. Two of them (22%) had a preterm birth. Since the number of subjects was too 
small, we could not identify any significant association. On the other hand, there are few 
studies that show that ART is associated with small for gestational age.20,22 The association 
of adverse pregnancy outcomes with nevirapine has been clearly demonstrated and is now 
not recommended due to its toxicity.23 In this study, no mother took nevirapine.
There are several limitations to our study. First, the small number of subjects limits the 
generalizability of our study, and its retrospective nature limits our ability to make any 
causal determinations. There could be women who were using contraceptive methods, but 
the relationship between contraceptive methods and outcomes could not be evaluated due 
to the retrospective nature of this study. In addition, induced abortion or other pregnancy 
outcomes might have been done in other clinics and not reported to the study hospital. So, 
the pregnancy rate might be underestimated and maternal mortality and complications may 
have been overlooked. The pregnancy rate of HIV-infected women in Korea appears to be 
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lower than that of the general population. Although we observed several adverse outcomes 
including preterm delivery, low birth weight, small for gestational age, and neonatal death, 
mother-to-child transmission of HIV infection was successfully prevented with effective 
preventive measures. Further interventions to improve pregnancy outcomes for HIV-infected 
women are needed.
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